Factors involved in the discontinuation of antihypertensive drug therapy: An analysis from real life data

Journal of Hypertension

Volumn 32, Issue 8, 2014, Pages 1708-1716

  Mancia, Giuseppe ^a,b,c   Zambon, Antonella ^c   Soranna, Davide ^c   Merlino, Luca ^d   Corrao, Giovanni ^c  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b Centro Interuniversitario di Fisiologia Clinica e Ipertensione   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d Operative Unit of Territorial Health Services   (Italy)

Author keywords

antihypertensive drugs; databases; discontinuation; persistence

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; DATA BASE; DEMENTIA; DRUG WITHDRAWAL; FEMALE; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEOPLASM; NEUROLOGIC DISEASE; POPULATION DENSITY; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATIC DISEASE; HYPERTENSION; MEDICATION COMPLIANCE;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; MEDICATION ADHERENCE;

EID: 84904038888     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000222     Document Type: Article

References (50)

1. Corrao G, Zambon A, Parodi A, Poluzzi E, Baldi I, Merlino L, et al. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: A population-based study in Italy. J Hypertens 2008; 26:819-824. (Pubitemid 351354932)
2. Corrao G, Parodi A, Zambon A, Heiman F, Filippi A, Cricelli C, et al. Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. J Hypertens 2010; 28:1584-1590.
3. Nicotra F, Wettermark B, Sturkenboom MC, Parodi A, Bellocco R, Ekbom A, et al. Management of antihypertensive drugs in three European countries. J Hypertens 2009; 27:1917-1922.
4. Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, Mancia G. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens 2011; 29:610-618.
5. Corrao G, Zambon A, Parodi A, Merlino L, Mancia G. Incidence of cardiovascular events in Italian patients with early discontinuation of antihypertensive, lipid-lowering and antidiabetic treatments. Am J Hypertens 2012; 25:549-555.
6. Corrao G, Cesana G, Merlino L. Pharmacoepidemiological research and the linking of electronic healthcare databases available in the Italian region of Lombardy. BioMed Stat Clin Epidemiol 2008; 2:117-125.
7. Ray WA. Evaluating medication effects outside of clinical trials: newuser designs. Am J Epidemiol 2003; 158:915-920. (Pubitemid 37323253)
8. Brookhart MA, Sturmer T, Glynn RJ, Rassen J, Schneeweiss S. Confounding control in healthcare database research challenges and potential approaches. Med Care 2010; 48 (Suppl 1):S5-S8.
9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al., The Task Force for the management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). 2007 Guidelines for the Management of Arterial Hypertension. J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
10. de Leeuw P. Secondary hypertension: diagnosis and treatment. In: Mancia G, Grassi G, Kjeldsen SE, editors. Manual of hypertension. London: Informa Healthcare; 2008. pp. 255-262.
11. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996; 275:1557-1560.
12. Berke O. Exploratory disease mapping: kriging the spatial risk function from regional count data. Int J Health Geogr 2004; 3:18.
13. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: The importance of actual practice data. CMAJ 1999; 160:41-46. (Pubitemid 29054225)
14. Degli Esposti E, Sturani A, Di Martino M, Falasca P, Novi MV, Baio G, Buda S. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 2002; 16:439-444. (Pubitemid 34685595)
15. Hasford J, Mimran A, Simons WR. A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Hum Hypertens 2002; 16:569-575. (Pubitemid 35021364)
16. Bourgault C, Sénécal M, Brisson M, Marentette MA, Grégoire JP. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: A population-based study. J Hum Hypertens 2005; 19:607-613. (Pubitemid 41131661)
17. Mazzaglia G, Mantovani L, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: A retrospective cohort study in primary care. J Hypertens 2005; 23:2093-2100. (Pubitemid 41830406)
18. Van Wijk BLG, Klungel OH, Heerdink ER, de Boer A. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens 2005; 23:2101-2107. (Pubitemid 41830407)
19. Burke TA, SturkenboomMC, Lu S-E, Wentworth CE, Lin Y, Rhoads GG. Discontinuation of hypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006; 24:1193-1200. (Pubitemid 43772328)
20. Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med 2007; 20:72-80. (Pubitemid 46219403)
21. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: A meta-analysis. Med Care 2002; 40:794-811.
22. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RS, Varney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333:15.
23. Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006; 113:203-212.
24. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006; 166:1842-1847. (Pubitemid 44455166)
25. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007; 297:177-186. (Pubitemid 46089734)
26. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 2008; 155:772-779. (Pubitemid 351410514)
27. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120:1598-1605.
28. Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, Falvey H, Vincze G, Klungel OH, Herings RM. The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin 2008; 24:121-127. (Pubitemid 351160245)
29. Kettani FZ, Dragomir A, Cote R, Roy L, Be rard A, Blais L, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009; 40:213-220.
30. Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bérard A. Better adherence to antihypertensive agents and risk reduction of chronic heart failure. J Intern Med 2009; 266:207-218.
31. Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bérard A. Adherence level of antihypertensive agents in coronary artery disease. Br J Clin Pharmacol 2010; 69:74-84.
32. Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010; 48:418-425.
33. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004; 19:357-362. (Pubitemid 38916494)
34. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006; 12:239-245. (Pubitemid 47400613)
35. Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, Koerselman J, Klungel OH, Falvey H, et al. Effect of persistent use of antihypertensives on blood pressure goal attainment. Curr Med Res Opin 2008; 24:1025-1031. (Pubitemid 351579159)
36. Vaur L, Vaisse B, Genes N, Elkik F, Legrand C, Poggi L. Use of electronic pill boxes to assess risk of poor treatment compliance: results of a largescale trial. Am J Hypertens 1999; 12:374-380. (Pubitemid 29200055)
37. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206. (Pubitemid 37430058)
38. Amar J, Chamontin B, Genes N, Cantet C, Salvador M, Cambou JP. Why is hypertension so frequently uncontrolled in secondary prevention? J Hypertens 2003; 21:1199-1205. (Pubitemid 36667875)
39. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population: results from the third national Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305-311.
40. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al., Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357.
41. Authors/Task Force Members. ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, prediabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34:3035-3087.
42. The Task Force for the management of dyslipidemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ESC/EAS guidelines for the management of dyslipidemias. Eur Heart J 2011; 32:1769-1818.
43. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160:2101-2107. (Pubitemid 30482715)
44. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications. The impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002; 17:504-511. (Pubitemid 34989157)
45. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10:697-704. (Pubitemid 27313814)
46. Corrao G, Zambon A, Parodi A, Mezzanzanica M, Merlino M, Cesana G, Mancia G. Do socioeconomic disparities affect accessing and keeping antihypertensive drug therapy? Evidence from an Italian populationbased study. J Hum Hypertens 2009; 23:238-244.
47. Mancia G, Parodi A, Merlino L, Corrao G. Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class. J Hypertens 2011; 29:1012-1018.
48. Corrao G, Conti V, Merlino L, Catapano AL, Mancia G. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Clin Ther 2010; 32:300-310.
49. Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC, Motola D, et al. Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol 2005; 61:603-609. (Pubitemid 41414244)
50. Motola D, Vaccheri A, Silvani MC, Poluzzi E, Bottoni A, De Ponti F, Montanaro N. Pattern of NSAID use in the Italian general population: A questionnaire-based survey. Eur J Clin Pharmacol 2004; 60:731-738.